Results

Total Results: 1,211 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/musculoskeletal-disorders-imaging_research-protocol.pdf
    August 05, 2010 - Evidence-based Practice Center Technical Brief Protocol Project Title: Technical Brief - Use and Safety … It requires that the patient be placed in a tube lying flat, either prone or supine. … What are the potential safety issues and harms of positional MRI technologies? … i Types of patients/patient selection criteria: inclusion and exclusion criteria, characteristics of … enrolled patients (demographics, disease spectrum).
  2. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ischemic-stroke-treatment_executive.pdf
    January 01, 2011 - report: author identification, year of publication, study design characteristics, study population, patient … different types of neurothrombectomy devices, what are the type(s) of devices, study designs and sizes, patientpatient discharge. … We did not draw conclusions regarding their effectiveness or safety. … the topic, including randomized controlled trials to determine the optimal device(s) to use, and the patient
  3. Obesity (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - safety evaluation. … , thus disrupting the current health care model for this patient population. … data and postmarket safety evaluation—set forth by FDA. … data and postmarket safety evaluation—set forth by FDA. … would view lorcaserin if it demonstrates safety and efficacy in a majority of patients.
  4. Obesity (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - of administration would be unlikely to deter liraglutide use if it demonstrates safety and efficacy … Duo positively if it demonstrates safety and efficacy in clinical trials. … , thus disrupting the current health care model for this patient population. … data and postmarket safety evaluation—set forth by FDA. … if it demonstrates both short- and long-term safety and efficacy in a majority of patients.
  5. effectivehealthcare-admin.ahrq.gov/products/recombinant-factor-viia/clinician
    March 01, 2020 - rFVIIa) in the hospital setting has increased despite limited comparative data on its effectiveness and safety … How is it being used, and what is the evidence of benefits and harms for treated patients? … Food and Drug Administration has approved rFVIIa for the treatment and prevention of bleeding in patients … results of this review are summarized here for use in your decisionmaking and in discussions with patients … Hemorrhage and Adult Cardiac Surgery   In-Hospital, Off-Label Use of rFVIIa TE Events/Total Patients
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
    May 01, 2024 - Director, General Patient Safety Program Center for Quality Improvement and Patient Safety Agency … effectiveness of patient safety practices (PSPs). … safety progress,”7 a claim supported by a recent meta- analysis indicating that as many as 1 in 20 patients … the purpose of improving patient safety. … safety practices Patient Safety Practice Summary of Final Advice Categorization of Final Advice 1
  7. effectivehealthcare-admin.ahrq.gov/products/retention-strategies-opioid-use-disorder/rapid-protocol
    May 01, 2020 - EHC The Evidence-based Practice Centers The Scientific Resource Center Registry of Patient … incarcerated) Intervention/Exposure Any strategy (or adjunct to MAT) that impacts the retention of patientsPatient Navigation Models for Lung Cancer.  Rapid Evidence Product. … Human Development Indices and Indicators: 2018 Statistical Update . 2018. … Safety Practices and Ratings by a Technical Expert Panel, 2023-2024 Research Protocol
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rfviia.pptx
    May 01, 2010 - The talk will cover the current evidence on the effectiveness and safety of using recombinant activated … Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the … Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation … Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation … Safety is defined via thromboembolic events and mortality, but individual studies often lack the statistical
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/rfviia.pptx
    May 01, 2010 - The talk will cover the current evidence on the effectiveness and safety of using recombinant activated … Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the … Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation … Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation … Safety is defined via thromboembolic events and mortality, but individual studies often lack the statistical
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
    November 09, 2011 - , routine surveillance for patients at admission  Identifying patients at risk for suicide  … safety practice is applied to a patient safety problem in order to improve beneficial patient safetySafety Practice Patient Safety Problem Contexts - Safety Culture, Teamwork, Leadership … of Patient Safety Practices – Developing Criteria 3 I. … Assessing the Evidence for Context-Sensitive Effectiveness and Safety of Patient Safety Practices:
  11. Obesity (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - were uncertain regarding long-term safety and efficacy. … The yearly cost per patient would be about $13,000 at current pricing. … , which has yet to be established in this patient population. … declining because of safety concerns. … for similar reasons, but mentioned long-term safety as a concern.
  12. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - abuse by increasing the perceived safety of a harmful behavior. … Commercial clients pay annual licensing fees for CaringTXT, prorated on projected patient populations … CaringTXT annual licenses cost about $12,000 to $18,000 for an average-sized university or college client … Across all client types, patients pay for text messages only if the service is not included in their … As of June 2015, CaringTXT was in use by clients including the University of Pittsburgh and the Central
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - The 2006 CER revealed safety concerns for the erythropoietic stimulants as a class. … In an individual patient data meta-analysis of 13,933 patients in 53 trials treated with epoetin alfa … analyzed individual patient data from 2,122 patients in 6 trials receiving darbepoetin alpha finding … Study and Independent Patient Level Meta-Analysis Selection: Results from study- and patient-level meta-analysis … Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data
  14. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
    September 01, 2011 - are made in the report, its conclusions should have clinical applicability because they laid out the safety … Objective outcomes addressed include esophagitis healing, ambulatory pH, other indicators of reflux, … placebo in improving asthma symptoms, nocturnal asthma, or use of asthma medications, or in objective indicators … Administrative databases can provide additional data for addressing long-term safety issues. … Objective outcomes addressed include esophagitis healing, ambulatory pH, other indicators of reflux,
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
    October 01, 2010 - . ��� Increased risk for arterial thromboembolic events, particularly at doses >40 µg/kg of patient … though the effect of treating spontaneous intracranial hemorrhage with rFVIIa at doses ≤40 μg/kg of patient … rFVIIa) in the hospital setting has increased despite limited comparative data on its effectiveness and safety … How is it being used, and what is the evidence of benefits and harms for treated patients? … In-Hospital, Off-Label Use of rFVIIa TE Events/Total Patients (%) Risk Difference Summary Effect Size
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
    August 01, 2015 - Patient Stakeholder Baltimore, MD Ruth Horowitz, M.D. … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention … Study design: Endpoint Classification: Safety Study Intervention Model: Single Group Assignment … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention … Study design: Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
    October 19, 2016 - Patient Safety in Ambulatory Settings. Technical Brief No. 27. … And appropriate anti-‐ coagulation was not considered a safety issue, though patients are hurt badly … Is this a big problem affecting patients? Which issues cause the most patient harm? … Guiding Question #1 concerned patient safety practices. … This patient safety practice has already been adopted by NQF’s Patient Safety Measures in 2007, approved
  18. effectivehealthcare-admin.ahrq.gov/products/prehospital-airway-management/research
    August 01, 2021 - EHC The Evidence-based Practice Centers The Scientific Resource Center Registry of Patient … Construct comparisons that are more clearly defined by specific emergency types, patient groups, and … No conclusion was supported by high SOE for any comparison and patient group. … 14, 2021 Systematic Review AHRQ and the National Highway Traffic SafetySafety Practices and Ratings by a Technical Expert Panel, 2023-2024 Rapid Evidence Product
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
    December 14, 2017 - Due to safety issues, the use of leuprolide is limited for only 3 months. … bleeding and statistically significant improvements in women’s symptom and health-related quality-of-life indicators … had much less time to get pregnant than the myomectomy patients. … US patients are different than European (or other patients) in that there is greater direct appeal by … pharma, device companies and providers to the consumer (patient).
  20. effectivehealthcare-admin.ahrq.gov/products/horizon-scan/research
    July 01, 2019 - EHC The Evidence-based Practice Centers The Scientific Resource Center Registry of Patient … Executive Summary With funding from the American Recovery and Reinvestment Act of 2009 (ARRA) and the Patient-Centered … You Might Also Like Research Protocol Dec 12, 2024 Impact of Healthcare Worker Safety … White Paper Jul 27, 2023 Making Healthcare Safer IV: Final Report on Prioritization of PatientSafety Practices for a New Rapid Review or Rapid Response Research Protocol Jun 02, 2023

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: